1-3 of 3
Thomas Krausz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial

Available to Purchase
Jason J. Luke, Benjamin E. Onderdonk, Sandeep R. Bhave, Theodore Karrison, Jeffrey M. Lemons, Paul Chang, Yuanyuan Zha, Tim Carll, Thomas Krausz, Lei Huang, Carlos Martinez, Linda A. Janisch, Robyn D. Hseu, John W. Moroney, Jyoti D. Patel, Nikolai N. Khodarev, Joseph K. Salama, Patrick A. Ott, Gini F. Fleming, Thomas F. Gajewski, Ralph R. Weichselbaum, Sean P. Pitroda, Steven J. Chmura
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (24): 6437–6444.
https://doi.org/10.1158/1078-0432.CCR-20-1790
Published: 15 December 2020
View articletitled, Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial
Open the PDF for Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial in another window
Includes: Supplementary data
Journal Articles

Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis

Free
Marion Zillhardt, Sun-Mi Park, Iris L. Romero, Kenjiro Sawada, Anthony Montag, Thomas Krausz, S. Diane Yamada, Marcus E. Peter, Ernst Lengyel
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 4042–4051.
https://doi.org/10.1158/1078-0432.CCR-10-3387
Published: 15 June 2011
View articletitled, Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
Open the PDF for Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis in another window
Includes: Supplementary data
Journal Articles

c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma

Free
Neelu Puri, Salman Ahmed, Varalakshmi Janamanchi, Maria Tretiakova, Osvaldo Zumba, Thomas Krausz, Ramasamy Jagadeeswaran, Ravi Salgia
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 2246–2253.
https://doi.org/10.1158/1078-0432.CCR-06-0776
Published: 02 April 2007
View articletitled, c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma
Open the PDF for c-Met Is a Potentially New Therapeutic Target for Treatment of Human Melanoma in another window
Includes: Supplementary data